NCAM1 and cancer: Cytokine-induced killer (CIK) cells are a population of cytotoxic T lymphocytes, which are characterized by the CD3 + CD56 + phenotype, and display wide MHC-unrestricted antitumor activity and potential effectiveness against several cancer types [3, 4].